STOCK TITAN

Broadway Financial Corp/Del (BYFC) Financials

BYFC
Trailing 12 months to June 30, 2026
Revenue $38.5M +14.2% YoY
Net Income -$20.7M -18746.4% YoY
EPS (Diluted) -$2.75 -663.9% YoY
Free Cash Flow $6.2M +230.5% YoY
Market Cap $107.7M as of Oct 13, 2026
Price / Sales 2.8x on $38.5M revenue, trailing 12 months to June 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book 0.4x on $262.3M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BYFC SEC filings page.

Broadway Financial Corp/Del (BYFC) reported $38.5M in revenue over the twelve months to Jun 30, 2026, up 14.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BYFC FY2025

The business runs a large, heavily financed asset base, and FY2025’s earnings collapse was not matched by operating-cash deterioration.

FY2025 paired a net loss of $24.8M with positive operating cash flow of $230K, showing that the reported earnings shock was not mirrored by routine cash operations. Free cash flow was -$13K, pointing to a substantial accounting-to-cash gap rather than a comparable cash drain.

Assets rose from $1.09B in FY2021 to $1.35B in FY2025, so the business has expanded the balance sheet it must earn against rather than operating mainly through a light asset base. Debt-to-equity moved from 3.7x in FY2024 to 4.1x in FY2025, while interest expense reached $28.1M; that structure makes returns sensitive to financing costs.

Net profitability fell from 5.8% in FY2024 to -71.1% in FY2025, indicating a sharp reversal rather than gradual margin pressure. Return on assets reached -1.8%, showing that the setback affected earnings relative to the entire asset base, not just per-share results.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Earnings Growth Capital Efficiency CreditQuality Stability 20 / 100
Financial Health Score 20/100
Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Broadway Financial Corp/Del's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings
11

Broadway Financial Corp/Del earned a return on assets of -1.8% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is down from 0.1% the prior year. Earnings ranks banks on that return over three years, and Broadway Financial Corp/Del scores 11/100 among other banks.

Growth
17

Broadway Financial Corp/Del reported revenue of $34.9M in fiscal year 2025, against $33.3M in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Broadway Financial Corp/Del scores 17/100 among other banks.

Capital
85

Broadway Financial Corp/Del funded 19.5% of its assets with shareholders' equity at the end of fiscal year 2025, holding $262.8M of equity against $1.3B of assets. Capital ranks banks on that cushion, and Broadway Financial Corp/Del scores 85/100 among other banks.

Efficiency
4

Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. Broadway Financial Corp/Del scores 4/100 on it among other banks.

Credit Quality
0

Not available for Broadway Financial Corp/Del, and counted as zero in the overall score.

Stability
5

Broadway Financial Corp/Del reported a net loss of $24.8M in fiscal year 2025, against $1.9M in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and Broadway Financial Corp/Del scores 5/100 among other banks.

Piotroski F-Score Partial
3/5

Broadway Financial Corp/Del passes 3 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 2 of 4 profitability signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Broadway Financial Corp/Del reported a net loss of $24.8M while generating $230K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$10.4M
YoY+28.7%
QoQ+8.3%
5Y CAGR+5.4%
10Y CAGR+13.1%

Broadway Financial Corp/Del generated $10.4M in revenue in Q2 2026. This represents an increase of 28.7% from the same quarter a year earlier. Against the prior quarter it is up 8.3%.

Net Income
$968K
YoY+28.7%
QoQ-16.5%
5Y CAGR+6.7%
10Y CAGR+11.7%

Broadway Financial Corp/Del reported $968K in net income in Q2 2026. This represents an increase of 28.7% from the same quarter a year earlier. Against the prior quarter it is down 16.5%.

EPS (Diluted)
$0.02
5Y CAGR+14.9%
10Y CAGR+7.2%

Broadway Financial Corp/Del earned $0.02 per diluted share (EPS) in Q2 2026.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow
$3.7M
YoY+24.7%
QoQ+241.7%
10Y CAGR+18.0%

Broadway Financial Corp/Del generated $3.7M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 24.7% from the same quarter a year earlier. Against the prior quarter it is up 241.7%.

Cash & Debt
$48.9M
YoY+65.7%
QoQ+83.8%
5Y CAGR-25.3%
10Y CAGR+3.2%

Broadway Financial Corp/Del held $48.9M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding
Diluted avg 9M

Broadway Financial Corp/Del had a weighted average of 9M diluted shares in Q2 2026; the shares outstanding count is not reported for that period.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Net Margin
9.3%
YoY0.0pp
QoQ-2.7pp
5Y change+0.5pp
10Y change-1.2pp

Broadway Financial Corp/Del's net profit margin was 9.3% in Q2 2026, showing the share of revenue converted to profit. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 2.7 percentage points.

Return on Equity
0.4%
YoY+0.1pp
QoQ-0.1pp
5Y change-0.1pp
10Y change-0.3pp

Broadway Financial Corp/Del's ROE was 0.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures
$311K
YoY+2292.3%
QoQ+842.4%
5Y CAGR+50.0%
10Y CAGR+37.4%

Broadway Financial Corp/Del invested $311K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 2292.3% from the same quarter a year earlier. Against the prior quarter it is up 842.4%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

BYFC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BYFC quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$10.4M+28.7%$9.6M+15.7%$9.4M+10.1%$9.0M+3.4%$8.1M-1.0%$8.3M+6.4%$8.6M-26.4%$8.7M+23.1%
SG&A Expenses$4.3M-3.6%$4.9M-7.5%$4.8M-33.4%$4.3M-2.1%$4.4M-1.3%$5.3M+23.8%$7.2M-7.0%$4.4M+1.2%
Interest Expense$8.3M+25.2%$7.2M+5.9%$7.6M-7.9%$7.2M-13.3%$6.6M-17.0%$6.8M-7.1%$8.2M+42.7%$8.3M+60.6%
Income Tax$330K+11.5%$282K+126.0%$392K-25.2%$736K+257.3%$296K+112.9%-$1.1M-1911.1%$524K-55.5%$206K+402.4%
Net Income$968K+28.7%$1.2M+143.1%$1.0M-21.8%-$23.9M-4728.5%$752K+193.8%-$2.7M-1646.1%$1.3M-49.7%$516K+448.9%
EPS (Basic)$0.02$0.05+112.8%$0.04-33.3%-$2.86-9433.3%$0.00-100.0%-$0.39-1850.0%$0.06-79.3%-$0.03-400.0%
EPS (Diluted)$0.02$0.05$0.04-33.3%-$2.86-9433.3%$0.00-100.0%-$0.39-1850.0%$0.06-$0.03-400.0%
Diluted Shares (Avg)9M+0.8%9MN/A9M+1.1%9M+2.5%9M+3.9%9M9M-3.5%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

BYFC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BYFC quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$1.6B+25.3%$1.4B+13.3%$1.3B+0.8%$1.3B-4.9%$1.2B-10.8%$1.3B-10.2%$1.3B-5.1%$1.4B+10.7%
Cash & Equivalents$48.9M+65.7%$26.6M+68.5%$10.5M-82.9%$19.7M-79.7%$29.5M-67.1%$15.8M-76.5%$61.4M-41.7%$97.1M+745.1%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
GoodwillN/AN/A$0-100.0%$0-100.0%$25.9M0.0%$25.9M0.0%$25.9M0.0%$25.9M0.0%
Total Liabilities$1.3B+35.2%$1.2B+19.3%$1.1B+3.1%$1.1B-4.0%$962.6M-13.8%$975.0M-13.0%$1.0B-6.7%$1.1B+12.5%
Total Equity$262.3M-7.9%$262.5M-7.4%$262.8M-7.8%$261.7M-8.6%$284.7M+0.9%$283.6M+0.9%$285.0M+1.2%$286.2M+4.2%
Retained Earnings-$14.6M-257.3%-$14.8M-259.7%-$15.2M-219.7%-$15.3M-218.2%$9.3M-25.5%$9.3M-23.9%$12.7M+2.9%$13.0M+33.0%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

BYFC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BYFC quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$4.0M+34.5%$1.1M+125.9%-$2.3M+20.6%$3.8M-37.5%$3.0M-69.2%-$4.3M+62.7%-$2.8M-179.6%$6.1M+223.9%
Depreciation & Amortization$109K+4.8%$108K+5.9%$103K+232.1%$101K-42.3%$104K-36.2%$102K-37.8%-$78K+25.7%$175K+4.8%
Capital Expenditures$311K+2292.3%$33K+120.0%$109K+1111.1%$106K+265.5%$13K-71.1%$15K-72.7%$9K-90.4%$29K-64.6%
Free Cash Flow$3.7M+24.7%$1.1M+125.1%-$2.4M+17.0%$3.7M-38.9%$3.0M-69.2%-$4.4M+62.8%-$2.9M-182.0%$6.1M+237.0%
Investing Cash Flow-$117.1M-567.5%-$68.2M-314.2%-$13.4M-142.5%-$122.9M-54944.2%$25.0M+27.6%$31.8M+237.6%$31.6M+145.2%$224K+102.9%
Financing Cash Flow$135.3M+1044.2%$83.2M+213.8%$6.5M+110.0%$109.2M+11697.4%-$14.3M-113.4%-$73.1M-2135.2%-$64.5M-140.3%$926K-86.2%
Dividends PaidN/AN/AN/AN/AN/A$750KN/A$750K

Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.

BYFC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BYFC quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Net Margin9.3%0.0pp12.0%+44.3pp10.9%-4.4pp-264.2%9.3%+6.1pp-32.3%-30.3pp15.3%-7.1pp5.9%+4.6pp
Return on Equity0.4%+0.1pp0.4%+1.4pp0.4%-0.1pp-9.1%-9.3pp0.3%+0.2pp-0.9%-0.9pp0.5%-0.5pp0.2%+0.1pp
Return on Assets0.1%0.0pp0.1%+0.3pp0.1%0.0pp-1.8%-1.8pp0.1%0.0pp-0.2%-0.2pp0.1%-0.1pp0.0%0.0pp
Debt-to-Equity4.96+1.6x4.43+1.0x4.12+0.4x4.10+0.2x3.38-0.6x3.44-0.5x3.68-0.3x3.91+0.3x
Asset Turnover0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x
FCF Margin35.8%-1.2pp11.3%+63.7pp-25.1%+8.2pp41.1%-28.5pp37.0%-52.4%-33.3%-63.2pp69.6%+44.2pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Broadway Financial Corp/Del BYFC FY2025 $34.9M -$24.8M -71.0% $107.7M 20/100
Central Plains Bancshares, Inc. CPBI FY2026 $21.3M $4.0M 18.7% $77.8M 42/100
Bank of the James Financial Group, Inc BOTJ FY2025 $48.7M $9.0M 18.5% $122.4M 52/100
First US Bancshares, Inc. FUSB FY2025 $41.0M $6.0M 14.6% $90.3M 29/100
IF Bancorp, Inc. IROQ FY2025 $25.8M $4.3M 16.7% $86.2M 31/100
First Northwest Bancorp FNWB FY2025 $68.9M -$4.2M -6.1% $93.5M 11/100

Frequently Asked Questions

What is Broadway Financial Corp/Del's annual revenue?

Broadway Financial Corp/Del (BYFC) reported $34.9M in total revenue for fiscal year 2025. This represents a 4.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Broadway Financial Corp/Del's revenue growing?

Broadway Financial Corp/Del (BYFC) revenue grew by 4.7% year-over-year, from $33.3M to $34.9M in fiscal year 2025.

Is Broadway Financial Corp/Del profitable?

No, Broadway Financial Corp/Del (BYFC) reported a net income of -$24.8M in fiscal year 2025, with a net profit margin of -71.0%.

Broadway Financial Corp/Del (BYFC) reported diluted earnings per share of -$3.23 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Broadway Financial Corp/Del (BYFC) had a net profit margin of -71.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Broadway Financial Corp/Del (BYFC) has a return on equity of -9.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Broadway Financial Corp/Del (BYFC) recorded an outflow of $13K in free cash flow during fiscal year 2025. This represents a -101.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Broadway Financial Corp/Del (BYFC) generated $230K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Broadway Financial Corp/Del (BYFC) had $1.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Broadway Financial Corp/Del (BYFC) invested $243K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Broadway Financial Corp/Del (BYFC) had a debt-to-equity ratio of 4.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Broadway Financial Corp/Del (BYFC) had a return on assets of -1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Broadway Financial Corp/Del (BYFC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $107.7M as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Broadway Financial Corp/Del (BYFC) trades at 2.8x sales, its market capitalization divided by revenue of $38.5M revenue, trailing 12 months to June 30, 2026. The market capitalization is $107.7M as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Broadway Financial Corp/Del (BYFC) has a Piotroski F-Score of 3 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Broadway Financial Corp/Del (BYFC) reported a net loss of $24.8M while generating $230K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Broadway Financial Corp/Del (BYFC) scores 20 out of 100 on our Financial Health Score, indicating weak standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top